Last updated: September 25, 2023
Sponsor: University Hospital, Geneva
Overall Status: Active - Recruiting
Phase
N/A
Condition
N/ATreatment
Mechanical ventilation by HFJV
General anesthesia for laryngotracheal surgery
Mechanical ventilation by FCV
Clinical Study ID
NCT06063798
BASEC2022-D0078
SNCTP000005183
Ages 18-100 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Informed Consent signed by the subject
- General anesthesia for laryngotracheal surgery
- Adult patients, female and male, over 18 years of age
- Elective surgery
Exclusion
Exclusion Criteria:
- Documented severe heart conditions (New York Heart Association Class 4, severepulmonary hypertension)
- Documented severe respiratory disease (uncontrolled asthma, severe pulmonary fibrosis,chronic obstructive pulmonary disease GOLD 4)
- Documented severe Neurological diseases (Acute ischemic and hemorrhagic stroke withinthe preceding 3 months, uncontrolled seizures)
- Surgery that requires tracheotomy
- Obesity (Body Mass Index ≥ 30 kg/m2)
- Inability to follow the procedures of the study (mental condition or language barriere.g. incomprehension of French language)
- Previous enrolment into the current study or other study that involves unknownmedication in the past 12 months
- Allergy or contraindication to Propofol and/or Remifentanil and/or Rocuronium
Study Design
Total Participants: 50
Treatment Group(s): 3
Primary Treatment: Mechanical ventilation by HFJV
Phase:
Study Start date:
September 05, 2023
Estimated Completion Date:
December 31, 2025
Study Description
Connect with a study center
Geneva University Hospitals
Geneva, 1211
SwitzerlandActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.